HUWE1 promotes EGFR ubiquitination and degradation to protect against renal tubulointerstitial fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HUWE1 promotes EGFR ubiquitination and degradation to protect against renal tubulointerstitial fibrosis

Published:2020-02-04 Issue:3 Volume:34 Page:4591-4601
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zhu Qian¹,Dong Hao¹,Bukhari Ashfaq‐Ahmad‐Shah¹,Zhao Anran¹,Li Min²,Sun Yifei¹,Zhang Xue¹,Cao Changchun³,Su Dongming²⁴,Liang Xiubin¹³

Affiliation:

1. Department of Pathophysiology Nanjing Medical University Nanjing China

2. Department of Pathology Nanjing Medical University Nanjing China

3. Department of Nephrology The Affiliated Sir Run Run Hospital of Nanjing Medical University Nanjing China

4. Center of Pathology and Clinical Laboratory The Affiliated Sir Run Run Hospital of Nanjing Medical University Nanjing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201902751R

Reference38 articles.

1. Common pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives

2. The Burden of Chronic Kidney Disease on Developing Nations: A 21st Century Challenge in Global Health

3. Cellular and molecular mechanisms of renal fibrosis

4. Progression and potential regression of glomerulosclerosis

5. Renal fibrosis: Insights into pathogenesis and treatment

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Status and role of the ubiquitin–proteasome system in renal fibrosis;Biomedicine & Pharmacotherapy;2024-09

2. pSTAT3 transactivates EGFR in maintaining EGFR protein homeostasis and EGFR-TKI resistance;Acta Biochimica et Biophysica Sinica;2024-09-01

3. Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies;Frontiers in Pharmacology;2024-08-21

4. PTEN in kidney diseases: a potential therapeutic target in preventing AKI-to-CKD transition;Frontiers in Medicine;2024-08-06

5. Post-translational modifications in kidney diseases and associated cardiovascular risk;Nature Reviews Nephrology;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3